Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
Research shows it may influence nitric oxide signaling and cytokine activity
Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy
Follow these three steps: Enter Vial Size Input the total peptide content of your vial in milligrams (mg)
